SCHEMBL29478793

SCHEMBL29478793

CC1(C)CCc2c(cc(Br)c(C#N)c2Br)C1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.34
▸ CES1 P23141 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24373031 1.00 MAPK1 (0.34) MAPK1CES1
SCHEMBL29478872 0.76 CES1 (0.33) CES1
SCHEMBL24373030 0.76 CES1 (0.33) CES1
SCHEMBL24373453 0.74 ALDH1A1 (0.34) MAPK1
SCHEMBL29479151 0.74 ALDH1A1 (0.34) MAPK1
SCHEMBL25608607 0.70 MAPK1 (0.37) MAPK1CES1
SCHEMBL24373461 0.66 — —
SCHEMBL29478826 0.66 — —
SCHEMBL30421685 0.64 CES1 (0.41) CES1
SCHEMBL31619448 0.63 MEN1 (0.39) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232444-A1 HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2023-08-30 — — EP disclosed
WO-2022083569-A1 HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2022-04-28 — — WO disclosed
Send feedback